SerpinB3 drives cancer stem cell survival in glioblastoma is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T32AI007024
National Institutes of Health
Grant: F30CA250254
National Institutes of Health
Grant: K99CA248611
National Institutes of Health
Grant: R01 NS117104
National Institutes of Health
Grant: R35 NS127083
National Institutes of Health
Grant: T32GM007250
NINDS NIH HHS
Grant: R01 NS102669
NCI NIH HHS
Grant: P01 CA245705
NIAID NIH HHS
Grant: T32 AI007024
NCATS NIH HHS
Grant: TL1 TR002549
NINDS NIH HHS
Grant: R01 NS109742
European Commission
Grant: 250254
Microbial Network Organisation
National Institutes of Health
Grant: 1R01NS117104-01
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma
National Institutes of Health
Grant: 5T32AI007024-22
TRAINING IN GEOGRAPHIC MEDICINE AND INFECTIOUS DISEASES
National Institutes of Health
Grant: 5F30CA250254-04
Role of SerpinB3 in glioblastoma cancer stem cells
National Institutes of Health
Grant: 5R01NS109742-03
Deciphering MDSC function for GBM targeting
National Institutes of Health
Grant: 5TL1TR002549-03
NRSA Training Core
National Institutes of Health
Grant: 5T32GM007250-46
Medical Scientist Training Program
National Institutes of Health
Grant: 5P01CA245705-02
Sex-based Differences in Glioma
National Institutes of Health
Grant: 1R35NS127083-01
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma
National Institutes of Health
Grant: 1K99CA248611-01A1
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
American Brain Tumor Association
Merck
Rutgers, The State University of New Jersey
Bayer Fund
Bristol-Myers Squibb
AbbVie
Case Comprehensive Cancer Center, Case Western Reserve University
AstraZeneca
Karyopharm Therapeutics
FWCI
1.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals